Back to Trades
KIRSKE DAVID
Chief Financial OfficerCIK 0001276750
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Across 5 filings between 2025–2026, KIRSKE DAVID, Chief Financial Officer, has disclosed $4.9M in transactions — all concentrated in X4 Pharmaceuticals, Inc (XFOR). Their disclosed trades are heavily weighted toward selling — $0 in buys and $70.1K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Oct 5 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Sell | $33.7K |
| Jul 1 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Sell | $36.4K |
| Oct 31 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Award | $2.2M |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Grant | $2.6M |
| Aug 14 | XFOR X4 Pharmaceuticals, Inc | KIRSKE DAVID | Chief Financial Officer | Other | $0 |
5 filings